Stephen Mahoney
Overview
Stephen Mahoney received an average of $1M in total compensation, including $379K in salary, at Dianthus Therapeutics between 2022 and 2023. Stephen Mahoney also received $12M at Signal Genetics in 2023 and an average of $2M at Kiniksa Pharmaceuticals, Ltd. from 2017 to 2019.
- 2023
- 2022
- 2019
- 2018
- 2017
Dianthus TherapeuticsFormer President, Chief Financial and Operating Officer
Signal GeneticsPresident, Chief Executive Officer and Director
Dianthus TherapeuticsFormer President, Chief Financial and Operating Officer
Kiniksa Pharmaceuticals, Ltd.Former President and Chief Operating Officer
Kiniksa Pharmaceuticals, Ltd.President and Chief Operating Officer
Kiniksa Pharmaceuticals, Ltd.President and Chief Operating Officer
Source: SEC filings on April 11, 2024, April 26, 2024, April 28, 2020, and April 17, 2019.
Related executives
We found 27 more executives who work or worked at Dianthus Therapeutics, Signal Genetics, andKiniksa Pharmaceuticals, Ltd..
Scott Myers
Signal Genetics
Chief Executive Officer
Seth Harmon
Signal Genetics
Senior Vice President of Finance and Accounting
Thomas Beetham
Signal Genetics
Chief Operating Officer
Jonathan Violin
Signal Genetics
Chief Executive Officer
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019